disease | Hemorrhagic Disease of the Newborn |
alias | Hemorrhagic Disease of the Newborn |
Hemorrhagic disease of the newborn refers to spontaneous bleeding in newborns caused by vitamin K deficiency.
bubble_chart Etiology
The following reasons cause vitamin K deficiency: (1) The fetus mainly relies on its own synthesis for vitamin K, but due to the immature liver function of the fetus, the synthesis of vitamin K is affected; (2) At birth, the newborn's intestines are sterile, which affects the synthesis of vitamin K in the intestines; (3) The vitamin K content in breast milk is low, and breastfeeding infants receive less vitamin K; (4) Liver and gallbladder diseases, antibiotic use, diarrhea, etc., all affect the synthesis and absorption of vitamin K.
The coagulation biological activity of clotting factors II, VII, IX, and X directly depends on the presence of vitamin K. The levels of these vitamin K-dependent factors are low at birth, especially factors II and VII, which are only 25–60% of normal levels. When they drop below 20% within 48–72 hours, there may be a tendency for spontaneous bleeding. Levels gradually return to birth levels after 10 days.
bubble_chart Clinical Manifestations
﹝Auxiliary Examination﹞
Red blood cell count and hemoglobin levels decrease, platelet count remains normal, clotting time is prolonged, and prothrombin time is extended.
For newborns who experience bleeding within the first week of birth, have no other disease manifestations, and appear normal, this condition should be considered. A prothrombin time prolonged to more than twice the control value is diagnostically significant; rapid improvement with vitamin K treatment can serve as an important diagnostic basis.
bubble_chart Treatment Measures
﹝Treatment﹞
(1) For cases with bleeding but no significant anemia, administer intravenous vitamin K1 at 3–5 mg/kg for 3 consecutive days; (2) If bleeding is severe, transfuse fresh whole blood or plasma at 10–15 ml/kg; (3) For massive bleeding leading to pallor and shock, transfuse 15–20 ml/kg within 5–10 minutes. If there is no significant improvement, with persistent low blood pressure and hemoglobin below 80–100 g/L, repeat the transfusion. If necessary, administer furosemide at 1 mg/kg simultaneously. Maintain hemoglobin above 120 g/L, along with normal blood pressure and pH.
(1) Intramuscular injection of 1 mg vitamin K1 after birth; (2) Intramuscular injection of 3-5 mg vitamin K1 for those with perinatal asphyxia or congenital gastrointestinal malformations; (3) Intramuscular injection of vitamin K for 3-5 days before delivery if there is a possibility of vitamin K deficiency during pregnancy.